NeoPharm CO., LTD. (KOSDAQ:092730)
South Korea · Delayed Price · Currency is KRW 22,250
-50 (-0.22%)
Oct 30, 2026, 3:30 PM KST
NeoPharm CO., LTD. Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, NeoPharm CO., LTD. stock has a consensus rating of "Strong Buy" and an average price target of ₩30,500. The average 1-year stock price forecast is 37.08% higher than the current stock price, while the lowest is ₩30,000 (+34.83%) and the highest is ₩31,000 (+39.33%).
Price Target: ₩30,500 (+37.08%)
Analyst Consensus: Strong Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for NeoPharm CO., LTD. stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Nov '25 | Jan '26 | Jun '26 | Jul '26 | Aug '26 | Oct '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 2 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 1 | 1 | 1 | 1 | 1 | 2 |
Financial Forecast
Revenue This Year
169.00B
from 132.18B
Increased by 27.85%
Revenue Next Year
207.00B
from 169.00B
Increased by 22.49%
EPS This Year
2.12K
from 1.78K
Increased by 19.28%
EPS Next Year
2.54K
from 2.12K
Increased by 19.60%
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is KRW.